Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Virtually Better: The Science and Practice of Therapeutic Virtual Reality, 2/26/2021 8:00:00 AM - 2/26/2024 9:00:00 AM, Dr. Spiegel introduces the novel use and efficacy of virtual reality (VR) for the treatment of physical pain and mental health disorders. He offers evidence for how VR can be used to influence the “theater of the mind” and mimics the use of psychedelics in manipulating the emotional and physical components of pain. Dr. Spiegel discusses the potential for using VR therapy in multiple healthcare settings where there are promising results.
Presenter
Brennan Spiegel, MD, MSHS
Professor of Medicine and Public Health
Director of Health Services Research, Cedars-Sinai
Director, Master’s Degree Program in Health Delivery Science
Cedars-Sinai Site Director, Clinical and Translational Science Institute (CTSI)
Assistant Dean, David Geffen School of Medicine at UCLA
Co-Editor-in-Chief, American Journal of Gastroenterology
About our presenter:
Dr. Brennan Spiegel directs a multidisciplinary team that investigates how digital health technologies, including wearable biosensors, smartphone applications, virtual reality, and social media, can improve people’s lives. His team developed one of largest and most widely documented medical virtual reality programs at Cedars-Sinai. Dr. Spiegel has published numerous best-selling medical textbooks, editorials, and more than 215 articles in peer-reviewed journals. He is listed in the "Top 100 Influencer" lists for digital health and virtual reality. His digital health research has been featured by major media outlets, including Bloomberg, CBS News, Forbes, Huffington Post, LA Times, NBC News, Reuters, The Washington Post and The Wall Street Journal.
Learning Outcome(s)
Participants will be able to consider the role and evidence for using VR for managing acute and chronic pain, as well as anxiety, depression, schizophrenia, and other mental health disorders, and discuss how to set up and implement a VR consultation service.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Brennan Spiegel, MD, MSHS
Professor of Medicine and Public Health
Director of Health Services Research, Cedars-Sinai
Director, Master’s Degree Program in Health Delivery Science
Cedars-Sinai Site Director, Clinical and Translational Science Institute (CTSI)
Assistant Dean, David Geffen School of Medicine at UCLA
Co-Editor-in-Chief, American Journal of Gastroenterology
About our presenter:
Dr. Brennan Spiegel directs a multidisciplinary team that investigates how digital health technologies, including wearable biosensors, smartphone applications, virtual reality, and social media, can improve people’s lives. His team developed one of largest and most widely documented medical virtual reality programs at Cedars-Sinai. Dr. Spiegel has published numerous best-selling medical textbooks, editorials, and more than 215 articles in peer-reviewed journals. He is listed in the "Top 100 Influencer" lists for digital health and virtual reality. His digital health research has been featured by major media outlets, including Bloomberg, CBS News, Forbes, Huffington Post, LA Times, NBC News, Reuters, The Washington Post and The Wall Street Journal.
Learning Outcome(s)
Participants will be able to consider the role and evidence for using VR for managing acute and chronic pain, as well as anxiety, depression, schizophrenia, and other mental health disorders, and discuss how to set up and implement a VR consultation service.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
